[The clinical analysis of plakophilin-2 gene mutation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia].

Autor:	Liu X, Liu W; Cardiology Center, Peking University People's Hospital, Beijing 100044, China; Email: wlliu@21cn.com., Hu D, Zhang L, Zhu T, Li C, Qiu X, Li L, Guo C, Liu X, Wang L, Zheng H, Wang C, Diao Q, Shi D, Zhan P, Deng Y, Liu K, Wang Y, Liu B, Liu H, Qin X, Lan Y
Jazyk:	čínština
Zdroj:	Zhonghua nei ke za zhi [Zhonghua Nei Ke Za Zhi] 2015 Dec; Vol. 54 (12), pp. 1001-6.
Abstrakt:	Objective: The purpose of this study was to screen genetic variations in plakophilin-2 (PKP2) gene in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) and investigate the differences in clinical features between mutation and no-mutation groups. Methods: Thirty unrelated Chinese patients clinically diagnosed with ARVC/D and 50 healthy controls were included. Genomic DNA was isolated from peripheral blood samples. PCR and direct sequencing were used to detect variations in PKP2 gene. Results: Eight PKP2 mutant variants were identified in 10 ARVC/D patients (8 men, 2 women). Among the eight mutation, three (c.2194C>T, c. 1170+ 1G>A and c. 810_813delGGTC) were novel mutation. Clinical features of the PKP2 mutation group were similar to those of the non-mutation group. Conclusions: The rate of PKP2 mutation is 33.3% (10/30) in ARVC/D patients. The penetrance of PKP2 mutation for ARVC/D tends to be higher in man patients. No significant differences could be detected in phenotype characteristics between patients with and without PKP2 mutation.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu